BridgeMD
New treatment option for Post Stroke Shoulder Pain
Official title To Evaluate the Therapeutic Effect of Laser Acupuncture in Patients With Acute or Subacute Post Stroke Shoulder Pain
ClinicalTrials.gov ID: NCT05328401
What this study is testing
- What it's testing
- Investigators propose a research design protocol to evaluate the efficacy of laser acupuncture in improving shoulder pain and improving shoulder function recovery after stroke.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- Beyond the age of 20.
- Normal consciousness before and after stroke who can reply and fill in the questionnaire.
- Subacute (subacute phase: 7 days to 6 months after stroke) and Chronic (chronic phase: more than 6 months after stroke) with shoulder pain after...
- Stop taking painkillers for more than 1 day,
- Without received intramuscular drugs (steroids, botulinum toxin, glucose, etc.) injections in the shoulder joint or around the shoulder for more than...
You likely can't join if
- Participants with shoulder pain symptoms before the stroke
- Acute shoulder trauma on the affected side of shoulder pain in the past.
- Surgery on the affected side of shoulder pain in the past.
- Those who cannot complete the scale assessment due to aphasia, post-stroke depression, and obvious cognitive impairment.
- Women who are pregnant or planning to become pregnant.
- Those who have a history of epilepsy and are receiving anti-epileptic drug treatment.
See the full eligibility criteria
- Beyond the age of 20.
- Normal consciousness before and after stroke who can reply and fill in the questionnaire.
- Subacute (subacute phase: 7 days to 6 months after stroke) and Chronic (chronic phase: more than 6 months after stroke) with shoulder pain after stroke and in post- stroke recovery period.
- Stop taking painkillers for more than 1 day,
- Without received intramuscular drugs (steroids, botulinum toxin, glucose, etc.) injections in the shoulder joint or around the shoulder for more than 2 weeks
- Those willing to sign the written subject consent form.
- Participants with shoulder pain symptoms before the stroke
- Acute shoulder trauma on the affected side of shoulder pain in the past.
- Surgery on the affected side of shoulder pain in the past.
- Those who cannot complete the scale assessment due to aphasia, post-stroke depression, and obvious cognitive impairment.
- Women who are pregnant or planning to become pregnant.
- Those who have a history of epilepsy and are receiving anti-epileptic drug treatment.
- Who are receiving any herbal or folk remedies related to shoulder pain.
- Any other conditions deemed unsuitable in the assessment of the responsible physician.
- Those who have not signed the written subject consent form.
The study team makes the final eligibility decision.
Where it's taking place
- Keelung, Taiwan, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Keelung, Taiwan, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.